• Tue, November 13, 2012

by: WOPRAI

Porter Bancorp Inc (NASDAQ:PBIB), Down By 11.00% ($0.11) From $1.000 After BUYINS.NET Report Predicted Stock Would Go Down Due

by: WOPRAI

VirtualScopics Inc (NASDAQ:VSCP), Up By 9.86% ($0.07) From $0.710 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bu

by: WOPRAI

dELiA*s Inc (NASDAQ:DLIA), Down By 5.47% ($0.07) From $1.280 After BUYINS.NET Report Predicted Stock Would Go Down Due To Beari

by: WOPRAI

DARA Biosciences Inc (NASDAQ:DARA), Down By 8.97% ($0.07) From $0.780 After BUYINS.NET Report Predicted Stock Would Go Down Due

by: WOPRAI

Lakeland Industries Inc (NASDAQ:LAKE), Down By 6.30% ($0.37) From $5.870 After BUYINS.NET Report Predicted Stock Would Go Down

by: WOPRAI

CODI SqueezeTrigger Price is $14.00. There is $4,902,045 That Short Sellers Still Need To Cover.

by: WOPRAI

HOLL SqueezeTrigger Price is $1.39. There is $14,544 That Short Sellers Still Need To Cover.

by: WOPRAI

BCS SqueezeTrigger Price is $14.89. There is $124,374,753 That Short Sellers Still Need To Cover.

by: WOPRAI

HBC SqueezeTrigger Price is $48.19. There is $249,252,051 That Short Sellers Still Need To Cover.

by: WOPRAI

DAL SqueezeTrigger Price is $10.42. There is $115,735,840 That Short Sellers Still Need To Cover.

by: WOPRAI

Medical Marijuana Inc (OTC:MJNA), Down By 70.21% ($0.07) From $0.094 After BUYINS.NET Report Predicted Stock Would Go Down Due

by: WOPRAI

Cannabis Science Inc (OTC:CBIS), Down By 19.05% ($0.01) From $0.063 After BUYINS.NET Report Predicted Stock Would Go Down Due T

by: WOPRAI

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), Down By 5.29% ($0.12) From $2.270 After BUYINS.NET Report Predicted Stock Would Go Do

by: WOPRAI

Seven Arts Pictures PLC (OTC:SAPX), Up By 255.93% ($0.15) From $0.059 After BUYINS.NET Report Predicted Stock Would Go Up Due T

by: WOPRAI

Wuxi Pharmatech (Cayman) Inc (NYSE:WX), Up By 6.49% ($0.93) From $14.320 After BUYINS.NET Report Predicted Strength After Earni

by: WOPRAI

Tsakos Energy Navigation Ltd (NYSE:TNP), Up By 8.04% ($0.34) From $4.230 After BUYINS.NET Report Predicted Strength Before Earn

by: WOPRAI

WPRT SqueezeTrigger Price is $26.53. There is $400,491,736 That Short Sellers Still Need To Cover.

by: WOPRAI

VCI SqueezeTrigger Price is $25.13. There is $296,943,535 That Short Sellers Still Need To Cover.

by: WOPRAI

TMP SqueezeTrigger Price is $39.46. There is $16,765,056 That Short Sellers Still Need To Cover.

by: WOPRAI

APPY, Has Remained On Naked Short Lists 13 Consecutive Days

by: WOPRAI

NSPH SqueezeTrigger Price is $2.95. There is $10,156,556 That Short Sellers Still Need To Cover.

by: WOPRAI

CSTR, ONCY, IPB, HLIT, TGP, NILE Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

NUVA, KONG, VRNT, NAVG, LVS, SIVB Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

BKBK, DSW, ZUMZ, LINC, CFFN, CMTL Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

POWR, VMW, PXH, OZM, ROX, GDX Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

MFG, EDU, IRBT, INP, RWM, PAG Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

MWA, PTH, SLX, APEI, PRIM, KNDI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

KOP, GPRE, TESO, BCPC, AAWW, HPY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

NDSN, OSIS, ARE, CHA, CZNC, BAS Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SPG, PSB, SLGN, SPRT, ALOG, IDT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

IDU, XKE, CRNT, ALNC, BOBE, TEVA Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

PETM, HOTT, ANW, SPB Expected To Be Up After Next Earnings Releases

by: WOPRAI

GCO, CSIQ Expected To Be Up Before Next Earnings Releases

by: WOPRAI

RWC, GSAT, VELT, WYY, SB, AMCF Expected To Be Down After Next Earnings Releases

by: WOPRAI

MBND, NTES, ULTR, ULGX, DRYS, LWAY Expected To Be Down After Next Earnings Releases

by: WOPRAI

LTXC Expected To Be Down Before Next Earnings Releases

by: WOPRAI

Daniel Kurnos Maintained (SSP) at Strong Buy with Increased Target to $13 on, Nov 13th, 2012

by: WOPRAI

Troy Jensen Upgraded (SSYS) to Buy and Held Target at $76 on, Nov 13th, 2012

by: WOPRAI

Michael Lasser Maintained (WSM) at Hold with Increased Target to $24 on, Nov 13th, 2012

by: WOPRAI

Robert Koort Upgraded (ALB) to Strong Buy and Increased Target to $67 on, Nov 13th, 2012

by: WOPRAI

John Boylan Downgraded (SYY) to Hold on, Nov 13th, 2012

by: WOPRAI

Edward Tenthoff Maintained (ALNY) at Hold with Decreased Target to $19 on, Nov 13th, 2012

by: WOPRAI

Thomas Diffely Maintained (AMAT) at Strong Buy with Decreased Target to $15 on, Nov 13th, 2012

by: WOPRAI

Anthony Pettinari Initiated (BERY) at Strong Buy and Held Target at $18 on, Nov 13th, 2012

by: WOPRAI

George Staphos Initiated (BERY) at Strong Buy and Held Target at $20 on, Nov 13th, 2012

by: WOPRAI

Adam Samuelson Initiated (BERY) at Strong Buy and Held Target at $17 on, Nov 13th, 2012

by: WOPRAI

Ghansham Panjabi Initiated (BERY) at Buy and Held Target at $20 on, Nov 13th, 2012

by: WOPRAI

Steven Delaney Upgraded (ARI) to Buy on, Nov 13th, 2012

Edward Tenthoff Maintained (ALNY) at Hold with Decreased Target to $19 on, Nov 13th, 2012

Edward Tenthoff of Piper Sandler, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $20 to $19 on, Nov 13th, 2012.

Edward, nor any peers, have made any analyst calls on ALNY in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍